Wellington Management Group’s Boston Scientific BSX Stock Holding History

Wellington Management Group’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.18B	Buy	18,833,406 +9,124,317	+94%	+$730M	0.22%	108
2025 Q4	$926M	Sell	9,709,089 -4,944,352	-34%	-$485M	0.16%	147
2025 Q3	$1.43B	Sell	14,653,441 -17,996,024	-55%	-$1.86B	0.25%	91
2025 Q2	$3.51B	Sell	32,649,465 -548,377	-2%	-$55.5M	0.64%	28
2025 Q1	$3.35B	Sell	33,197,842 -2,967,557	-8%	-$299M	0.64%	33
2024 Q4	$3.23B	Buy	36,165,399 +3,344,571	+10%	+$294M	0.59%	32
2024 Q3	$2.75B	Buy	32,820,828 +718,515	+2%	+$56.6M	0.48%	49
2024 Q2	$2.47B	Sell	32,102,313 -1,186,504	-4%	-$86.8M	0.44%	47
2024 Q1	$2.28B	Sell	33,288,817 -3,152,310	-9%	-$203M	0.4%	56
2023 Q4	$2.11B	Sell	36,441,127 -5,635,402	-13%	-$301M	0.39%	59
2023 Q3	$2.22B	Buy	42,076,529 +2,336,348	+6%	+$123M	0.44%	51
2023 Q2	$2.15B	Sell	39,740,181 -6,761,474	-15%	-$353M	0.41%	61
2023 Q1	$2.33B	Sell	46,501,655 -11,234,685	-19%	-$529M	0.46%	53
2022 Q4	$2.67B	Sell	57,736,340 -4,800,659	-8%	-$208M	0.54%	43
2022 Q3	$2.42B	Sell	62,536,999 -1,123,027	-2%	-$45.1M	0.52%	48
2022 Q2	$2.37B	Sell	63,660,026 -4,679,386	-7%	-$190M	0.48%	55
2022 Q1	$3.03B	Sell	68,339,412 -6,176,830	-8%	-$268M	0.52%	49
2021 Q4	$3.17B	Sell	74,516,242 -9,314,428	-11%	-$391M	0.51%	49
2021 Q3	$3.64B	Sell	83,830,670 -5,123,566	-6%	-$227M	0.62%	32
2021 Q2	$3.8B	Sell	88,954,236 -1,666,288	-2%	-$70.1M	0.63%	28
2021 Q1	$3.5B	Buy	90,620,524 +13,354,883	+17%	+$505M	0.62%	33
2020 Q4	$2.78B	Buy	77,265,641 +18,663,851	+32%	+$673M	0.51%	46
2020 Q3	$2.24B	Buy	58,601,790 +2,688,953	+5%	+$104M	0.46%	56
2020 Q2	$1.96B	Buy	55,912,837 +13,260,158	+31%	+$478M	0.44%	59
2020 Q1	$1.39B	Buy	42,652,679 +6,714,969	+19%	+$262M	0.37%	61
2019 Q4	$1.63B	Sell	35,937,710 -17,270,743	-32%	-$723M	0.34%	68
2019 Q3	$2.17B	Sell	53,208,453 -5,121,155	-9%	-$217M	0.49%	51
2019 Q2	$2.51B	Buy	58,329,608 +3,274,680	+6%	+$126M	0.56%	41
2019 Q1	$2.11B	Sell	55,054,928 -8,177,319	-13%	-$312M	0.48%	51
2018 Q4	$2.23B	Sell	63,232,247 -153,985	-0.2%	-$5.58M	0.56%	37
2018 Q3	$2.44B	Sell	63,386,232 -3,640,871	-5%	-$127M	0.51%	41
2018 Q2	$2.19B	Sell	67,027,103 -1,454,446	-2%	-$43.9M	0.49%	45
2018 Q1	$1.87B	Sell	68,481,549 -5,337,876	-7%	-$145M	0.42%	58
2017 Q4	$1.83B	Buy	73,819,425 +9,659,724	+15%	+$266M	0.4%	64
2017 Q3	$1.87B	Buy	64,159,701 +1,987,473	+3%	+$54.9M	0.43%	56
2017 Q2	$1.72B	Sell	62,172,228 -5,817,282	-9%	-$154M	0.41%	63
2017 Q1	$1.69B	Sell	67,989,510 -1,598,442	-2%	-$38.9M	0.41%	60
2016 Q4	$1.51B	Sell	69,587,952 -6,925,502	-9%	-$151M	0.38%	69
2016 Q3	$1.82B	Sell	76,513,454 -14,281,164	-16%	-$341M	0.46%	58
2016 Q2	$2.12B	Sell	90,794,618 -12,583,908	-12%	-$272M	0.55%	45
2016 Q1	$1.94B	Buy	103,378,526 +8,643,058	+9%	+$152M	0.51%	51
2015 Q4	$1.75B	Buy	94,735,468 +6,065,892	+7%	+$109M	0.46%	54
2015 Q3	$1.46B	Buy	88,669,576 +7,294,818	+9%	+$125M	0.41%	57
2015 Q2	$1.44B	Buy	81,374,758 +7,635,935	+10%	+$136M	0.37%	64
2015 Q1	$1.31B	Buy	73,738,823 +2,992,714	+4%	+$47.3M	0.34%	69
2014 Q4	$937M	Buy	70,746,109 +9,501,673	+16%	+$121M	0.25%	90
2014 Q3	$723M	Buy	61,244,436 +9,490,419	+18%	+$120M	0.2%	112
2014 Q2	$661M	Buy	51,754,017 +6,613,611	+15%	+$86M	0.18%	120
2014 Q1	$610M	Sell	45,140,406 -3,173,499	-7%	-$41.7M	0.17%	130
2013 Q4	$581M	Sell	48,313,905 -5,891,443	-11%	-$69.6M	0.17%	142
2013 Q3	$636M	Sell	54,205,348 -28,757,423	-35%	-$311M	0.2%	111
2013 Q2	$769M	Buy	+82,962,771	New	+$704M	0.25%	90

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group's BSX Position: Q1 2026 in Review

Wellington Management Group increased its Boston Scientific (BSX) stake by 94% in Q1 2026, buying an estimated $730M and bringing the position to 18,833,406 shares worth $1.18B. The position accounts for 0.22% of the portfolio, ranked #108.

Wellington Management Group first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.8B in Q2 2021. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Wellington Management Group held 18,833,406 shares of Boston Scientific worth $1.18B as of Q1 2026.
Wellington Management Group bought 9,124,317 Boston Scientific shares in Q1 2026, an estimated $730M.
Boston Scientific made up 0.22% of Wellington Management Group's portfolio in Q1 2026, its #108 holding.
Wellington Management Group first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
Wellington Management Group's Boston Scientific position peaked at $3.8B in Q2 2021.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.